Results 101 to 110 of about 25,773 (228)

Combination of Peginterferon α-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B-an Indian experience

open access: yesAnnals of Hepatology, 2005
Introduction: Treatment strategies for chronic hepatitis B (CHB) using either interferon or Lamivudine can achieve sustained response in 30-40 % in HBeAg positive CHB.
Deepak N. Amarapurkar, Nikhil D. Patel
doaj   +1 more source

Hepatic Steatosis in People With Chronic Hepatitis B in Africa: Prevalence, Correlates, and Clinical Significance

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 11, November 2026.
ABSTRACT To address data gaps around metabolic liver disease in Africa, within the Hepatitis B in Africa Collaborative Network (HEPSANET), we evaluated participants with chronic hepatitis B virus infection (CHB) for steatotic liver disease (SLD) using transient elastography with controlled attenuation parameter (CAP).
Freeman W. Chabala   +52 more
wiley   +1 more source

Factors predicting retreatment for HBeAg-negative patients.

open access: yes, 2019
Factors predicting retreatment for HBeAg-negative patients.
Tsung-Hui Hu (349887)   +5 more
core   +1 more source

Safety, Tolerability and Antiviral Activity of GST‐HG131 in Chronic Hepatitis B: A Randomized, Double‐Blind Phase IIa Study

open access: yesLiver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background and Aims Chronic hepatitis B (CHB) remains a major global health burden. Current therapies rarely achieve a functional cure due to low rates of HBsAg clearance, the persistence of the viral replication template—covalently closed circular DNA (cccDNA)—and the need for lifelong treatment.
Yuming Guo   +22 more
wiley   +1 more source

HBeAg status in the four age cohorts.

open access: yes, 2015
HBeAg status in the four age cohorts.
Leland Yee (706287)   +7 more
core   +1 more source

Triple Elimination of HIV, Syphilis and HBV Mother‐To‐Child Transmission in Africa: From a WHO Initiative to a Respondent‐Level Reality

open access: yes
Journal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
Erwan Vo‐Quang   +6 more
wiley   +1 more source

Immunological characteristics of HBeAg-negative HCC patients.

open access: yes, 2014
Immunological characteristics of HBeAg-negative HCC patients.
Meng Fang (473455)   +7 more
core   +1 more source

Factors predicting retreatment for HBeAg-positive patients.

open access: yes, 2019
Factors predicting retreatment for HBeAg-positive patients.
Tsung-Hui Hu (349887)   +5 more
core   +1 more source

Increasing hepatitis B viral load is associated with risk of signi¢cant liver ¢brosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B [PDF]

open access: yes, 2020
Background/aims: To evaluate the association between demographical features, serum ALT and HBV DNA and the prevalence of significant fibrosis and inflammation on liver biopsy in patients with chronic hepatitis B. Methods: In this cross-sectional study of
Paul V Desmond   +8 more
core  

Association of core promoter mutations of hepatitis B virus and viral load is different in HBeAg(+) and HBeAg(-) patients

open access: yesWorld Journal of Gastroenterology, 2011
To identify the prevalence of hepatitis B e antigen (HBeAg) and to assess the association of hepatitis B virus (HBV) core promoter mutations and viral load in Indonesian patients.Sixty-four patients with chronic hepatitis, 65 with liver cirrhosis and 50 with hepatocellular carcinoma were included in this study.
Andi, Utama   +16 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy